Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry

Haematologica

Volumn 92, Issue 12, 2007, Pages 1647-1654

  Giannini, Silvia ^a   Mezzasoma, Anna Maria ^a   Leone, Mario ^a   Gresele, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Desmopressin; Flow cytometry; Platelets; Von Willebrand factor; Von Willebrand's disease

Indexed keywords

DESMOPRESSIN; FORMALDEHYDE; RISTOCETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING AFFINITY; CHILD; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; HUMAN; LABORATORY DIAGNOSIS; MALE; MONITORING; SKIN BLEEDING; STATISTICAL SIGNIFICANCE; THROMBOCYTE; THROMBOCYTE RICH PLASMA; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BLEEDING TIME; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; FEMALE; FLOW CYTOMETRY; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PLATELET FUNCTION TESTS; RISTOCETIN; TIME FACTORS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 37049022399     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11313     Document Type: Article

References (18)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
2. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. The Italian Association of Hemophilia Centers (AICE). Haemophilia 2002;8:607-21.
3. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, et al. The working party on von Willebrand disease classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. J Thromb Haemost 2006;4:2103-14.
4. Favaloro E. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Semin Thromb Hemost 2006;32:456-71.
5. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. The ISTH SSC subcommitted on von Willebrand factor. J Thromb Haemost 2005;3:775-7.
6. Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies. Haemophilia 2001;7:180-9.
7. Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, et al. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Iba for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89:77-85.
8. Popov J, Zhukov O, Ruden S, Zeschmann T, Sferruzza A, Sahud M. Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease. Clin Chem 2006;52:1965-7.
9. Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100TM) with high sensitivity to disturbances in von Willebrand factor to screen von Willebrand disease and other disorders. Am J Hematol 1999;62:165-74.
10. Casonato A, Pontara E, Bertomoro A, Sartorello F, Cattini MG, Girolami A. von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity. Br J Haematol 2001;112: 578-83.
11. Lindahl TL, Fagerberg IH, Larsson A. A new flow cytometric method for measurement of von Willebrand factor activity. Scand J Clin Lab Invest 2003;63:217-24.
12. Franchini M, Gandini G, Manzato F, Lippi G. Evaluation of PFA-100 system for monitoring desmopressin therapy in patients with type 1 von Willebrand's disease. Haematologica 2002;87:670.
13. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90:2515-21.
14. Federici AB, Mazurier C, Berntorp E, Lee CA, Scharrer I, Goudemand J, et al. Biologic response to desmopressin in patients with sevete type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004;103:2032-8.
15. Ciferri S, Emiliani C, Guglielmini G, Orlacchio A, Nenci GG, Gresele P. Platelets release their lysosomal content in vivo in humans upon activation. Thromb Haemost 2000;83:157-64.
16. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Battle J, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2005;4:766-73.
17. Michelson AD, Barnard MR, Krueger LA, Furman MI. Flow cytometric analysis of platelet function. In: Gresele P, Page C, Fuster V, Vermylen J, Ed. Platelets in Thrombotic and Non-Thrombotic Disorders. London, UK, Cambridge; 2002:pp 485-98.
18. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980; 302:1047-51.